Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet

Affiliations

¹ Division of Transplant Surgery, University of California, San Francisco, California, USA. Electronic address: Flavio.Vincenti@ucsf.edu.
² Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
³ Division of Nephrology, University of Barcelona, Barcelona, Spain.
⁴ Department of Nephrology, Université Grenoble Alples, Saint-Martin- d'hères, France.
⁵ Department of Surgery, Duke University, Durham, North Carolina, USA.
⁶ Emory Transplant Center, Emory University, Atlanta, Georgia, USA.

Free article

Editorial

Flavio Vincenti et al. Am J Transplant. 2023 Oct.

Free article

. 2023 Oct;23(10):1483-1484.

doi: 10.1016/j.ajt.2023.05.033. Epub 2023 Jun 9.

¹ Division of Transplant Surgery, University of California, San Francisco, California, USA. Electronic address: Flavio.Vincenti@ucsf.edu.
² Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
³ Division of Nephrology, University of Barcelona, Barcelona, Spain.
⁴ Department of Nephrology, Université Grenoble Alples, Saint-Martin- d'hères, France.
⁵ Department of Surgery, Duke University, Durham, North Carolina, USA.
⁶ Emory Transplant Center, Emory University, Atlanta, Georgia, USA.

No abstract available

Keywords: Transplant; belatacept; costimulation.

Publication types